Divis Laboratories Total Debt vs. EBITDA
| DIVISLAB | 6,211 44.80 0.72% |
For Divis Laboratories profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Divis Laboratories to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Divis Laboratories Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Divis Laboratories's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Divis Laboratories Limited over time as well as its relative position and ranking within its peers.
Divis |
Divis Laboratories EBITDA vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Divis Laboratories's current stock value. Our valuation model uses many indicators to compare Divis Laboratories value to that of its competitors to determine the firm's financial worth. Divis Laboratories Limited is rated as one of the top companies in total debt category among its peers. It also is one of the top stocks in ebitda category among its peers totaling about 847.67 of EBITDA per Total Debt. At present, Divis Laboratories' EBITDA is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Divis Laboratories by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Divis Laboratories' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Divis Total Debt vs. Competition
Divis Laboratories Limited is rated as one of the top companies in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 91.53 Billion. Divis Laboratories adds roughly 30 Million in total debt claiming only tiny portion of equities under Health Care industry.
Divis EBITDA vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Divis Laboratories |
| = | 30 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Divis Laboratories |
| = | 25.43 B |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Divis EBITDA Comparison
Divis Laboratories is currently under evaluation in ebitda category among its peers.
Divis Laboratories Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Divis Laboratories, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Divis Laboratories will eventually generate negative long term returns. The profitability progress is the general direction of Divis Laboratories' change in net profit over the period of time. It can combine multiple indicators of Divis Laboratories, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 16.5 B | 17.3 B | |
| Operating Income | 18.3 B | 19.9 B | |
| Income Before Tax | 21.6 B | 13.7 B | |
| Net Income | 16 B | 13.6 B | |
| Income Tax Expense | 5.6 B | 3.1 B | |
| Total Other Income Expense Net | 3.3 B | 3.5 B | |
| Net Income From Continuing Ops | 16 B | 15.8 B | |
| Net Income Applicable To Common Shares | 21 B | 15.6 B | |
| Interest Income | 3 B | 3.2 B | |
| Net Interest Income | -30 M | -28.5 M | |
| Change To Netincome | 92.6 M | 97.2 M |
Divis Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Divis Laboratories. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Divis Laboratories position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Divis Laboratories' important profitability drivers and their relationship over time.
Use Divis Laboratories in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Divis Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Divis Laboratories will appreciate offsetting losses from the drop in the long position's value.Divis Laboratories Pair Trading
Divis Laboratories Limited Pair Trading Analysis
The ability to find closely correlated positions to Divis Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Divis Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Divis Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Divis Laboratories Limited to buy it.
The correlation of Divis Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Divis Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Divis Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Divis Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Divis Laboratories position
In addition to having Divis Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Information Technology ETFs Thematic Idea Now
Information Technology ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Information Technology ETFs theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Information Technology ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Divis Stock
To fully project Divis Laboratories' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Divis Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Divis Laboratories' income statement, its balance sheet, and the statement of cash flows.